3rd Annual Strategies and Techniques for IDENTIFICATION of NOVEL BIOACTIVE COMPOUNDS
	Cambridge Healthtech Institute (CHI) , Brussels, Belgium October 20-22, 1999
	The way in which discovery of novel therapeutic candidates is achieved has changed profoundly in the last decade. The challenge put forth of feeding drug candidates into the development pipeline is a rapidly evolving and complex process. The strategic design of compound libraries in a way which matches the knowledge of a given target is predicated on advanced computational analysis as well as efficient synthesis. There has been significant development in such areas as: novel synthesis strategies, library design, structure-based design, and virtual screening. The challenge to identify novel leads has driven the need for automated systems which can rapidly perform synthesis, purification and validation of compound libraries. These developments apply not only to the discovery of novel pharmaceutical compounds, but increasingly they are also being applied to the development of agricultural chemicals and a range of other applications. This conference is designed to provide a valuable forum for researchers involved in all aspects of this effort; molecular diversity, target identification, assay development, combinatorial library design and synthesis, development of other compound sources automation , chemoinformatics and integration of these components. A greater emphasis on the issues of purification and cost of compound libraries will be featured this year.
	Organized by:	Cambridge Healthtech Institute
	Deadline for Abstracts:	September 17, 1999
	Registration:	Please go to our website page to see the brochure and register on-line: http://www.healthtech.com/mhe/mhe.htm
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: wks137.healthtech.com date: May 21, 1999 17:43:51 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.